Amal Kamal Abdel-Aziz et al.
Basic & clinical pharmacology & toxicology, 116(1), 37-46 (2014-06-17)
Imatinib is a principal therapeutic agent for targeting colorectal tumours. However, mono-targeting by imatinib does not always achieve complete cancer eradication. Selenite, a well-known chemopreventive agent, is commonly used in cancer patients. In this study, we aimed to explore whether